Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash $ 189,855 $ 487,953
Accounts receivable - net of allowance of $309,979 and $344,412 as of September 30, 2020 and December 31, 2019, respectively 416,639 799,246
Inventory 991,309
Prepaid expenses and other assets 255,831 11,160
Total current assets 1,853,634 1,298,359
Property and equipment, net 77,153 105,199
Goodwill 8,366,467 8,366,467
Intangible assets, net 176,762 205,219
Other assets 17,561
Total assets 10,474,016 9,992,805
Current liabilities:    
Accounts payable and accrued liabilities 2,435,171 2,010,556
Accounts payable and accrued liabilities – related party 203,171  
Shareholder advance 475,000  
Deferred Revenue 1,641,720 1,056,637
Equity financing 515,000
Total current liabilities 5,270,062 3,067,193
Long-term liabilities:    
Loan payable 293,972
Total long-term liabilities 293,972  
Total liabilities 5,564,034 3,067,193
Commitments and contingencies
Stockholders’ equity:    
Series A Convertible Preferred stock, $0.001 par value; 900,000 shares authorized; 89,872 and 578,567 shares issued and outstanding, respectively 90 579
Common stock, $0.001 par value; 45,000,000 shares authorized; 9,845,600 and 7,390,261 shares issued and outstanding, respectively 9,846 7,391
Additional paid-in capital 25,341,185 19,712,115
Accumulated deficit (20,441,139) (12,794,473)
Total stockholders’ equity 4,909,982 6,925,612
Total liabilities and stockholders’ equity $ 10,474,016 $ 9,992,805